Ledger.Open graph →
SEC Form D · Amendment · filed February 8, 2013

BioAegis Therapeutics, Inc

Offering
$6.0M
Sold
$3.1M
Exemption
—
Industry
Biotechnology
Location
MORRISTOWN, NJ
Type
—

People & firms on this filing (3)

Richard Slaughter · San Diego, CADirectorCharles B. Krusen · NEW YORK, NYExec · DirectorNicholas D. Smith · SEBASTOPOL, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗